
Opinion|Videos|September 4, 2024
PSMA PET vs. Gallium-Based PET: Navigating NCCN Guidelines in Prostate Cancer Imaging
Author(s)Jaideep S. Sohi, MD, Jeremie Calais, MD
Jaideep Sohi, MD, and Jeremie Calais, MD, examine the comparative merits of PSMA PET and Gallium-Based PET while exploring the application of NCCN Guidelines in prostate cancer imaging protocols.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What are the NCCN Guidelines' recommendations for gallium-based versus non-gallium-based PET agents in prostate cancer imaging, and how does PSMA PET imaging impact prostate cancer care in your view?
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
The Inflection Point for AI in Radiology: Emerging Insights for 2026
2
Molecular Imaging in Focus: Emerging Insights on the PET and SPECT Imaging Agent 61Cu-NU101 for PCa
3
What New CCTA Research Reveals About Quantitative Plaque Assessment and Predicting MACE
4
SPECT/CT Agent Garners FDA Fast Track Designation for Inflammation Assessment in Interstitial Lung Disease
5















